# Adaptive Biotechnologies Corporation

- Location (FDA's records): Seattle, WA
- FDA decisions: 2 (2018–2020): 1 510(k) clearance and 1 De Novo grant
- Product codes: QDC (2)
- Predicates its devices cite: 1 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Its most-cited devices
- DEN170080: Adaptive Biotechnologies clonoSEQ Assay (2018), cited by 1

## Recent decisions
- K200009: Adaptive Biotechnologies clonoSEQ Assay (Aug 5, 2020)
- DEN170080: Adaptive Biotechnologies clonoSEQ Assay (Sep 28, 2018)

Source page: https://510kreport.com/company/adaptive-biotechnologies